Table of Contents

2019-2024 Global Benzodiazepine Drugs Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Benzodiazepine Drugs Consumption 2014-2024
  • 2.1.2 Benzodiazepine Drugs Consumption CAGR by Region
• 2.2 Benzodiazepine Drugs Segment by Type
  • 2.2.1 Alprazolam
  • 2.2.2 Clonazepam
  • 2.2.3 Diazepam
  • 2.2.4 Lorazepam
  • 2.2.5 Others
• 2.3 Benzodiazepine Drugs Consumption by Type
  • 2.3.1 Global Benzodiazepine Drugs Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Benzodiazepine Drugs Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Benzodiazepine Drugs Sale Price by Type (2014-2019)
• 2.4 Benzodiazepine Drugs Segment by Application
  • 2.4.1 Anxiety
  • 2.4.2 Insomnia
  • 2.4.3 Alcohol Withdrawal
  • 2.4.4 Seizures
  • 2.4.5 Others
• 2.5 Benzodiazepine Drugs Consumption by Application
  • 2.5.1 Global Benzodiazepine Drugs Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Benzodiazepine Drugs Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Benzodiazepine Drugs Sale Price by Application (2014-2019)

3 Global Benzodiazepine Drugs by Players

• 3.1 Global Benzodiazepine Drugs Sales Market Share by Players
  • 3.1.1 Global Benzodiazepine Drugs Sales by Players (2017-2019)
  • 3.1.2 Global Benzodiazepine Drugs Sales Market Share by Players (2017-2019)
• 3.2 Global Benzodiazepine Drugs Revenue Market Share by Players
  • 3.2.1 Global Benzodiazepine Drugs Revenue by Players (2017-2019)
  • 3.2.2 Global Benzodiazepine Drugs Revenue Market Share by Players (2017-2019)
• 3.3 Global Benzodiazepine Drugs Sale Price by Players
• 3.4 Global Benzodiazepine Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Benzodiazepine Drugs Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Benzodiazepine Drugs Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Benzodiazepine Drugs by Regions

• 4.1 Benzodiazepine Drugs by Regions
  • 4.1.1 Global Benzodiazepine Drugs Consumption by Regions
  • 4.1.2 Global Benzodiazepine Drugs Value by Regions
• 4.2 Americas Benzodiazepine Drugs Consumption Growth
• 4.3 APAC Benzodiazepine Drugs Consumption Growth
• 4.4 Europe Benzodiazepine Drugs Consumption Growth
• 4.5 Middle East & Africa Benzodiazepine Drugs Consumption Growth

5 Americas

• 5.1 Americas Benzodiazepine Drugs Consumption by Countries
  • 5.1.1 Americas Benzodiazepine Drugs Consumption by Countries (2014-2019)
  • 5.1.2 Americas Benzodiazepine Drugs Value by Countries (2014-2019)
• 5.2 Americas Benzodiazepine Drugs Consumption by Type
• 5.3 Americas Benzodiazepine Drugs Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Benzodiazepine Drugs Consumption by Countries
  • 6.1.1 APAC Benzodiazepine Drugs Consumption by Countries (2014-2019)
  • 6.1.2 APAC Benzodiazepine Drugs Value by Countries (2014-2019)
• 6.2 APAC Benzodiazepine Drugs Consumption by Type
• 6.3 APAC Benzodiazepine Drugs Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Benzodiazepine Drugs by Countries
  • 7.1.1 Europe Benzodiazepine Drugs Consumption by Countries (2014-2019)
  • 7.1.2 Europe Benzodiazepine Drugs Value by Countries (2014-2019)
• 7.2 Europe Benzodiazepine Drugs Consumption by Type
• 7.3 Europe Benzodiazepine Drugs Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Benzodiazepine Drugs by Countries
  • 8.1.1 Middle East & Africa Benzodiazepine Drugs Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Benzodiazepine Drugs Value by Countries (2014-2019)
• 8.2 Middle East & Africa Benzodiazepine Drugs Consumption by Type
• 8.3 Middle East & Africa Benzodiazepine Drugs Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Benzodiazepine Drugs Distributors
• 10.3 Benzodiazepine Drugs Customer

11 Global Benzodiazepine Drugs Market Forecast

• 11.1 Global Benzodiazepine Drugs Consumption Forecast (2019-2024)
• 11.2 Global Benzodiazepine Drugs Forecast by Regions
  • 11.2.1 Global Benzodiazepine Drugs Forecast by Regions (2019-2024)
  • 11.2.2 Global Benzodiazepine Drugs Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Benzodiazepine Drugs Forecast by Type
• 11.8 Global Benzodiazepine Drugs Forecast by Application

12 Key Players Analysis

• 12.1 Pfizer
  • 12.1.1 Company Details
  • 12.1.2 Benzodiazepine Drugs Product Offered
  • 12.1.3 Pfizer Benzodiazepine Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Pfizer News
• 12.2 F.Hoffmann-La Roche
  • 12.2.1 Company Details
  • 12.2.2 Benzodiazepine Drugs Product Offered
  • 12.2.3 F.Hoffmann-La Roche Benzodiazepine Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 F.Hoffmann-La Roche News
• 12.3 Bausch Health
  • 12.3.1 Company Details
  • 12.3.2 Benzodiazepine Drugs Product Offered
  • 12.3.3 Bausch Health Benzodiazepine Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Bausch Health News
• 12.4 Mylan
  • 12.4.1 Company Details
  • 12.4.2 Benzodiazepine Drugs Product Offered
  • 12.4.3 Mylan Benzodiazepine Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Mylan News
• 12.5 Teva Pharmaceutical Industries
  • 12.5.1 Company Details
  • 12.5.2 Benzodiazepine Drugs Product Offered
  • 12.5.3 Teva Pharmaceutical Industries Benzodiazepine Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Teva Pharmaceutical Industries News
• 12.6 H.Lundbeck
  • 12.6.1 Company Details
  • 12.6.2 Benzodiazepine Drugs Product Offered
  • 12.6.3 H.Lundbeck Benzodiazepine Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 H.Lundbeck News
• 12.7 Amneal Pharmaceuticals
  • 12.7.1 Company Details
  • 12.7.2 Benzodiazepine Drugs Product Offered
  • 12.7.3 Amneal Pharmaceuticals Benzodiazepine Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Amneal Pharmaceuticals News
• 12.8 Sun Pharmaceutical Industries
  • 12.8.1 Company Details
  • 12.8.2 Benzodiazepine Drugs Product Offered
  • 12.8.3 Sun Pharmaceutical Industries Benzodiazepine Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Sun Pharmaceutical Industries News
• 12.9 Apotex
  • 12.9.1 Company Details
  • 12.9.2 Benzodiazepine Drugs Product Offered
  • 12.9.3 Apotex Benzodiazepine Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Apotex News
• 12.10 Aurobindo Pharma
  • 12.10.1 Company Details
  • 12.10.2 Benzodiazepine Drugs Product Offered
  • 12.10.3 Aurobindo Pharma Benzodiazepine Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Aurobindo Pharma News

13 Research Findings and Conclusion

Benzodiazepines is a class of psychoactive drugs that are used to treat anxiety, insomnia, panic disorder, seizures, and alcohol withdrawal. These drug produce a calming effect by enhancing the effect of the neurotransmitter GABA. Benzodiazepines are widely prescribed drugs across the world. They are helpful to reduce anxiety, seizures, relax muscles, inducing sleep, and used for sedation purposes prior to surgery or general anesthesia.

According to this study, over the next five years the Benzodiazepine Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Benzodiazepine Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Benzodiazepine Drugs market by product type, application, key manufacturers and key regions and countries.

This study considers the Benzodiazepine Drugs value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Alprazolam
Clonazepam
Diazepam
Lorazepam
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Anxiety
Insomnia
Alcohol Withdrawal
Seizures
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
F.Hoffmann-La Roche
Bausch Health
Mylan
Teva Pharmaceutical Industries
H.Lundbeck
Amneal Pharmaceuticals
Sun Pharmaceutical Industries
Apotex
Aurobindo Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Benzodiazepine Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Benzodiazepine Drugs market by identifying its various subsegments.
Focuses on the key global Benzodiazepine Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Benzodiazepine Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Benzodiazepine Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.